Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

Pierluigi Tricoci, Yuliya Lokhnygina, Zhen Huang, Frans Van De Werf, Jan H. Cornel, Edmond Chen, Lars Wallentin, Claes Held, Philip E. Aylward, David J. Moliterno, Lisa K. Jennings, Harvey D. White, Paul W. Armstrong, Robert A. Harrington, John Strony, Kenneth W. Mahaffey

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: Results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science